US pulls up Amazon, others for selling unapproved health products; India sleeps over rampant trade


Content Team
Image Credit: FPJ

Even as the US finally came down heavily on its own e-comm companies, including the largest player Amazon, against selling unapproved drugs and consumer health products, India, a country where online trade in the healthcare segment is ballooning, seems oblivious of the same and its imminent dangers. About 14.2% sales in India’s $5.70 billion over-the-counter pharmaceuticals market is generated through online sales currently.